Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/18636
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPearson, Helen B-
dc.contributor.authorMcGlinn, Edwina-
dc.contributor.authorPhesse, Toby J-
dc.contributor.authorSchlüter, Holger-
dc.contributor.authorSrikumar, Anuratha-
dc.contributor.authorGödde, Nathan J-
dc.contributor.authorWoelwer, Christina B-
dc.contributor.authorRyan, Andrew-
dc.contributor.authorPhillips, Wayne A-
dc.contributor.authorErnst, Matthias-
dc.contributor.authorKaur, Pritinder-
dc.contributor.authorHumbert, Patrick-
dc.date2015-
dc.date.accessioned2018-08-30T06:34:04Z-
dc.date.available2018-08-30T06:34:04Z-
dc.date.issued2015-09-17-
dc.identifier.citationMolecular cancer 2015; 14: 169-
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/18636-
dc.description.abstractThe establishment and maintenance of polarity is vital for embryonic development and loss of polarity is a frequent characteristic of epithelial cancers, however the underlying molecular mechanisms remain unclear. Here, we identify a novel role for the polarity protein Scrib as a mediator of epidermal permeability barrier acquisition, skeletal morphogenesis, and as a potent tumor suppressor in cutaneous carcinogenesis. To explore the role of Scrib during epidermal development, we compared the permeability of toluidine blue dye in wild-type, Scrib heterozygous and Scrib KO embryonic epidermis at E16.5, E17.5 and E18.5. Mouse embryos were stained with alcian blue and alizarin red for skeletal analysis. To establish whether Scrib plays a tumor suppressive role during skin tumorigenesis and/or progression, we evaluated an autochthonous mouse model of skin carcinogenesis in the context of Scrib loss. We utilised Cre-LoxP technology to conditionally deplete Scrib in adult epidermis, since Scrib KO embryos are neonatal lethal. We establish that Scrib perturbs keratinocyte maturation during embryonic development, causing impaired epidermal barrier formation, and that Scrib is required for skeletal morphogenesis in mice. Analysis of conditional transgenic mice deficient for Scrib specifically within the epidermis revealed no skin pathologies, indicating that Scrib is dispensable for normal adult epidermal homeostasis. Nevertheless, bi-allelic loss of Scrib significantly enhanced tumor multiplicity and progression in an autochthonous model of epidermal carcinogenesis in vivo, demonstrating Scrib is an epidermal tumor suppressor. Mechanistically, we show that apoptosis is the critical effector of Scrib tumor suppressor activity during skin carcinogenesis and provide new insight into the function of polarity proteins during DNA damage repair. For the first time, we provide genetic evidence of a unique link between skin carcinogenesis and loss of the epithelial polarity regulator Scrib, emphasizing that Scrib exerts a wide-spread tumor suppressive function in epithelia.-
dc.language.isoeng-
dc.titleThe polarity protein Scrib mediates epidermal development and exerts a tumor suppressive function during skin carcinogenesis.-
dc.typeJournal Article-
dc.typeResearch Support, Non-U.S. Gov't-
dc.identifier.journaltitleMolecular cancer-
dc.identifier.affiliationSchool of Cancer Medicine at La Trobe University, Heidelberg, VIC, 3084, Australiaen
dc.identifier.affiliationDepartment of Biochemistry and Molecular Biology, The University of Melbourne, Parkville, VIC, 3010, Australiaen
dc.identifier.affiliationOlivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Pathology, The University of Melbourne, Parkville, VIC, 3010, Australiaen
dc.identifier.affiliationPeter MacCallum Cancer Centre, St Andrew's Place, East Melbourne, VIC, 3002, Australiaen
dc.identifier.affiliationEMBL Australia, Australian Regenerative Medicine Institute, Monash University, Clayton, VIC, 3800, Australiaen
dc.identifier.affiliationNational Center for Tumor Diseases Heidelberg (NCT), German Cancer Research Centre (DKFZ), 69120, Heidelberg, Germanyen
dc.identifier.affiliationTissuPath Laboratories, Mount Waverley, VIC, 3149, Australiaen
dc.identifier.affiliationSir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, 3010, Australiaen
dc.identifier.affiliationDepartment of Surgery (St. Vincent's Hospital), The University of Melbourne, Parkville, VIC, 3010, Australiaen
dc.identifier.affiliationWalter and Eliza Hall Institute of Medical Research, Melbourne, VIC, 3052, Australiaen
dc.identifier.doi10.1186/s12943-015-0440-z-
dc.identifier.orcid0000-0002-6399-1177-
dc.identifier.pubmedid26376988-
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.